twoXAR
AI-accelerated drug discovery
United States · $13.4M raised
- Headquarters
- California
- Employees
- 11–50
- Business Model
- B2B
- Website
- ariapharma.com
- Total Funding
- $13.4M
- Last Round
- $10.0M Series AMar 2018
- Rounds
- 2
About
twoXAR (rebranded as Aria Pharmaceuticals in 2021) is a preclinical-stage pharmaceutical company that uses AI and machine learning to analyze large biomedical datasets and identify novel small molecule drug candidates. The company focuses on therapeutic areas including oncology, dermatology, ophthalmology, and immunology, partnering with major pharmaceutical companies to accelerate drug discovery pipelines.
Summary
twoXAR is an Artificial Intelligence company based in United States. It has raised $13.4M in total across 2 rounds, most recently a $10.0M Series A round in Mar 2018. Investors include Andreessen Horowitz and Stanford-StartX Fund.
Funding History
Mar 2018
Sign up to see all 2 rounds
Seed through Series A — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic develops reliable, interpretable, and steerable AI systems, translating frontier safety...
xAI builds AI systems, including Grok, with frontier reasoning, voice, and generative media capab...
Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...
Databricks provides a unified data and AI platform that helps enterprises build and run applicati...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/twoxar"><img src="https://indexed.vc/api/badge/company/twoxar" alt="twoXAR on Indexed.vc" width="260" height="76" /></a>